
{
  "documentMetadata": {
    "title": "Pneumonia in neonates, age < 1 month",
    "sourceFile": "Pneumonia, Neonates, Age lt 1 month.pdf",
    "lastUpdated": "2025-05-05"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Clinical Setting"
    },
    {
      "type": "list",
      "items": [
        "Tachypnea with or without signs of increased work of breathing (grunting, nasal flaring, retractions) is the key symptom of pneumonia in infants age < 1 month.",
        "The bacterial etiologies of pneumonia in neonates mirror those of neonatal sepsis.",
        "Febrile neonates <30 days should be evaluated as for neonatal sepsis with blood culture, lumbar puncture and CBC. Tests for RSV, influenza and other respiratory viruses useful especially during fall and winter.",
        "Afebrile pneumonia syndrome usually seen after 2-4 weeks of age due to C. trachomatis, Mycoplasma hominis, Ureaplasma urealyticum and occasionally CMV or Pneumocystis jirovecii.",
        "This does not address ventilator associated pneumonia in intubated premature infant"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Etiologies"
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Early illness:"
        },
        {
          "type": "list",
          "items": [
            "Group B Streptococcus",
            "Escherichia coli",
            "Streptococcus pneumoniae",
            "RSV",
            "Less commonly other respiratory virus",
            "Staph aureus",
            "CMV",
            "Treponema pallidum",
            "Listeria monocytogenes",
            "Toxoplasma gondii"
          ]
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Later illness:"
        },
        {
          "type": "list",
          "items": [
            "Streptococcus pneumoniae",
            "Group B Streptococcus",
            "C. trachomatis",
            "Mycoplasma hominis",
            "Ureaplasma urealyticum",
            "RSV",
            "Influenza",
            "Human metapneumovirus",
            "Pneumocyctis jiroveci"
          ]
        }
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Primary Regimens"
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "strengthOfRecommendation": "Recommended",
        "components": [
          {
            "drug": "Ceftriaxone",
            "dose": "75-100 mg/kg/day",
            "frequency": "once daily",
            "notes": "may be used in term infants without hyperbilirubinemia"
          },
          {
            "drug": "Ampicillin",
            "connector": "+"
          },
          {
            "drug": "Gentamicin",
            "connector": "+"
          },
          {
            "drug": "Cefotaxime",
            "notes": "(where available)."
          }
        ]
      }
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "strengthOfRecommendation": "Recommended",
        "condition": "If methicillin-resistant Staph. aureus (MRSA) is a concern",
        "components": [
          {
            "drug": "Vancomycin",
            "dose": "60-80 mg/kg",
            "route": "IV",
            "frequency": "divided 3-4 times a day",
            "notes": "to achieve preferred target AUC24 400-600 µg/mL x hr (see vancomycin AUC dosing calculator; alternative is trough of 10-15 µg/mL but AUC targeting is preferred)."
          }
        ]
      }
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "strengthOfRecommendation": "Recommended",
        "condition": "For C. trachomatis",
        "components": [
          {
            "drug": "Erythromycin",
            "dose": "12.5 mg/kg",
            "route": "po or IV",
            "frequency": "qid x 14 days",
            "connector": "or"
          },
          {
            "drug": "Azithromycin",
            "dose": "10 mg/kg",
            "route": "po or IV",
            "frequency": "on day one then 5 mg/kg po or IV once daily for 4 days"
          }
        ]
      }
    },
    {
      "type": "table",
      "tableData": {
        "headers": ["Body Wt", "Age", "Dose"],
        "rows": [
          ["< 2000 gm", "≤ 7 days", "Ampicillin 50 mg/kg IV q12h"],
          ["", "", "Gentamicin 2.5 mg/kg IV q18-24h"],
          ["", "", "Cefotaxime* 50 mg/kg IV q12h"],
          ["", "7-28 days", "Ampicillin 50 mg/kg IV q8h"],
          ["", "", "Gentamicin 2.5 mg/kg IV q12h"],
          ["", "", "Cefotaxime* 50 mg/kg IV q8h"],
          ["≥ 2000 gm", "≤ 7 days", "Ampicillin 50 mg/kg IV q8h"],
          ["", "", "Gentamicin 2.5 mg/kg IV q12h"],
          ["", "", "Cefotaxime* 50 mg/kg IV q12h"],
          ["", "7-28 days", "Ampicillin 50 mg/kg IV q6h"],
          ["", "", "Gentamicin 2.5 mg/kg IV q 12h"],
          ["", "", "Cefotaxime* 50 mg/kg IV q8h"]
        ]
      },
      "notes": "* where available"
    },
    {
      "type": "header",
      "level": 1,
      "text": "Alternative Regimens"
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "strengthOfRecommendation": "Alternative",
        "components": [
          {
            "drug": "Cefepime",
            "dose": "150 mg/kg/day",
            "frequency": "div q8h"
          }
        ]
      }
    },
    {
      "type": "paragraph",
      "text": "If MRSA is documented, Vancomycin as above, Clindamycin, and Linezolid 10 mg/kg q8h are alternatives."
    },
    {
      "type": "paragraph",
      "text": "Dosing is weight- and/or age-based. See Comments."
    },
    {
      "type": "header",
      "level": 1,
      "text": "Antimicrobial Stewardship"
    },
    {
      "type": "list",
      "items": [
        "Limited data suggest low procalcitonin has high negative predictive value for bacterial pneumonia",
        "If viral infection is demonstrated and patient is improving, antibiotics can be discontinued",
        "Oseltamivir is indicated for treatment of influenza associated pneumonia in this age group"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "Vancomycin: traditional dosing of 45-60 mg/kg/day frequently does not achieve target AUC in term infants and older children with normal renal function. Use of AUC24 closer to 400 µg/mL adequate for most non-CNS infections. Clin Infect Dis Jul 13 2020",
        "Optimal duration of therapy is unknown. Short course therapy effective in adults; no good data in children",
        "Ceftriaxone is contraindicated in neonates if they require (or are expected to require) treatment with calcium-containing IV solutions, including continuous calcium-containing infusions such as total parenteral nutrition"
      ]
    }
  ]
}
